Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes

Histology and Histopathology

Volumn 24, Issue 1, 2009, Pages 61-67

  Pazzaglia, Laura ^a   Chiechi, Antonella ^a   Conti, Amalia ^a   Gamberi, Gabriella ^a   Magagnoli, Giovanna ^a   Novello, Chiara ^a   Morandi, Luca ^b   Picci, Piero ^a   Mercuri, Mario ^a   Benassi, Maria Serena ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b BELLARIA HOSPITAL   (Italy)

Author keywords

CGH microarray; Gene expression; Real Time PCR; Rhabdomyosarcoma

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN MCL 1; MAP2K4 PROTEIN, HUMAN; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER GENETICS; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL VIABILITY; CHILD; CHROMOSOME ARM; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; REGULATORY MECHANISM; RHABDOMYOSARCOMA; RNA ANALYSIS; AGED; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED DIAGNOSIS; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION; GENETICS; MIDDLE AGED; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; AGED; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MAP KINASE KINASE 4; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RNA, MESSENGER; SOFT TISSUE NEOPLASMS;

EID: 60549112596     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Anderson J., Gordon A., Pritchard-Jones K. and Shipley J. (1999). Gene chromosomes and rhabdomyosarcoma. Genes Chromosomes Cancer 26, 275-285.
2. Astolfi A., De Giovanni C., Landuzzi L., Nicoletti G., Ricci G., Croci S., Scopece L., Nanni P. and Lollini P. (2001). Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 274, 139-149.
3. Barr F.G. (2001). Gene fusion involving PAX and FOS family members in alveolar rhabdomyosarcoma. Oncogene 20, 5736-5746.
4. Barrett M.T., Scheffer A., Ben-Dor A., Sampas N., Lipson D., Kincaid R., Tsang P., Curry B., Baird K., Meltzer PS., Yakhini Z., Bruhn L. and Laderman S. (2004). Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. PNAS 101, 1765-1777.
5. Chae K.S., Ryu B.K., Lee M-G., Byun D.S. and Chi S.G. (2002). Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma. Eur. J. Cancer 38, 2048-2057.
6. Charge S.B. and Rudnicki M.A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
7. Cuenda A. (2000). Mitogen-activited protein kinase kinase 4 (MKK4). Int. J. Biochem. Cell Biol. 32, 581-587.
8. Davis R.J. (2000). Signal Transduction by the JNK Group of MAP Kinases Cell 103, 239-252.
9. Fleischer B., Schulze-Bergkamen H., Schuchmann M., Weber, A., Biesterfeld S., Muller M., Krammer P.H. and Galle P.R. (2006). Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int. J. Oncol. 28, 25-32.
10. Fletcher C.D.M., Unni K.K. and Martens F. (?002). World Health Organization: Classification of tumors pathology and genetics of tumours of Soft tissue and Bone. IARC press. Lyon (France). pp 146-154.
11. Fujise K., Zhang D., Liu J. and Yeh E.T. (2000). Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J. Biol. Chem. 275, 39458-39465.
12. Gallego M. and Sanchez de Toledo Codina J. (2007). Molecular biology of rhabdomyosarcoma. Clin. Transl. Oncol. 9, 415-419.
13. Goldstein M., Meller I., Issakov J. And Orr-Urtreger A. (2006). Novel genes implicated in embryonal, alveolar and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors. Neoplasia 8, 332-343.
14. Gordon A., McManus A., Anderson J., Fischer C., Abe S., Nojima T., Pritchard-Jones K. and Shipley J. (2003). Chromosomal imbalances in pleomorphic rhabdomosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case. Cancer Genet. Cytogenet. 140, 73-77.
15. Helman L.J. and Meltzer P. (2003). Mechanisms of sarcoma development. Nature Rev. Cancer 3, 685-694.
16. Holzmann K., Kohlhammer H., Schwaenen C., Wessendorf S., Kestler H.A., Schowoerer A., Rau B., Radlwimmer B., Dohner H., Lichter P., Gresss T. and Bentz M. (2004). Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res. 64, 4428-4433.
17. Ichijo H. (1999). From receptors to stress-activated MAP kinases, Oncogene 18, 6087-6093.
18. Kalebic T., Blakesley V., Slade C., Plasschaert S., Leroith D. and Heiman L.J. (1998). Expression of a kinase-deffeient lGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R. -Int. J. Cancer 76; 223-227.
19. Kim K.Y., Kovacs M., Kawamoto S., Seller J.R. and Adelstein R.S. (2005). Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C. J. Biol. Chem. 280, 22769-75.
20. Khan J., Bittner M.L., Saal L.H., Teichmann U., Azorsa D.O., Gooden G.C., Pavan W.J. Trent J.M. and Meltzer P.S. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. PNAS 96, 13264-13269.
21. Koyama T., Mikami T., Imakiire A., Yamamoto K., Toyota H. and Mizuguchi J. (2006). Apoptosis induced by chemotherapeutic agents involves c-Jun N- terminal kinase activation in sarcoma cell lines. J. Othop. Res. 24, 1153-1162.
22. Krajewski S., Bodrug S., Krajewska M., Shabaik A., Gascoyne R., Beren K. and Reed J.C. (1995). Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 146, 1309-1319.
23. Lee H.Y., Srinivas H., Xia D., Lu Y., Superty R., LaPushin R., Gomez-Manzano C., Gal A.M., Walsh G.L., Force T., Ueki K., Mills G.B. and Kurie J.M. (2003). Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-JunNK2-terminal kinase-dependent pathways cooperate to maintain lung cancer cell survival. J. Biol. Chem. 278, 23630-23638.
24. Lee J.Y. Jr and McCubrey J.A. (2002). The Raf/MEK/ERK signal transduction cascade as a target fot chemotherapeutic intervention in leukemia. Leukemia 16, 486-507.
25. Lingjaerde O.C., Baumbusch L.O., Liestol K., Glad I.K. and Borresen-Dale A.L. (2005). CGH-Explorer: a program for analysis of array-CGH. Bioinformatics 21, 821-822.
26. Merlino G. and Helman L.J. (1999). Rhabdomyosarcoma- working out in pathways. Oncogene 18, 5340-5348.
27. Morandi L., Marucci G., Foschini M.P., Cattani M.G., Pession A., Riva C. and Eusebi V. (2006). Genetic similarities and differences between lobular in situ neoplasia,(LN) and invasive lobular carcinoma of the breast. Virchows; Arch. 449, 14-23.
28. Pandita A., Zielenska M., Thorner P., Bayani J., Godbout R., Greenberg M. and Squire J.A. (1999). Application of comparative genomic hybridization, spectral karyotyping and microarray analysis in the identification of sub-type specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia 1, 262-275.
29. Ragazzini P., Gamberi G., Pazzaglia L., Serra M., Magagnoli G., Ponticelli F., Ferrari C., Ghinelli C., Alberghini M., Bretoni F., Picci P. and Benassi MS. (2004). Amplification of CDK4, MDM2,SAS, and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol. Histopathol. 19, 401-411.
30. Sambrook J., Fritsch E.F., Maniatis T. and Harbor C.S. (1989). Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press. New York.
31. Schubert K.M. and Duronio V. (2001). Distinct roles for extarcellular - signal-regulated protein kinase (ERK) mitogen-activated protein kinase and phosphotidylinositol 3-kinase in the regulation of MCL1-synthesis. Biochem. J. 356,473-480.
32. Shighemasa K., Katoh O., Shiroyama Y., Mihara S., Mukai K., Nagai N. and Ohama K. (2002). Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn. J. Cancer Res. 93, 542-50.
33. Thallinger C., Wolschek M.F., Maierhofer H., Skwara H., Pehamberger H., Monia B.P., Jansen B., Wacheck V. and Selzer E. (2004). MCL1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of MCL-1 antisense oligonucleoticles with low dose cyclophosphamide. Clin, Cancer Res, 10, 4185-4241.
34. Townsend K.J., Trusty J.L., Traupman M,A., Eastman A. and Graig R.W. (1998). Expression of antiapoptotic MCL1 gene product is regulated by mitogene activated protein kinases-mediated pathway triggered through microtubule disruption and protein kinases C. Oncogene 17, 1223-1234.
35. Wang L., Pan Y. and Dai J.L. (2004). Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 23, 5978-5985.
36. Wang X. and Studzinski G.P. (1997). Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp. Cell Res. 235, 210-217.
37. Weiss S.W. and Goldblum J.R. (2001). Malignant soft tissue tumors of incertain type. In: Enzinger and Weiss's eds, Soft tissue tumors (Fourth edition). St Louis. Mosby. pp 1483-1509.
38. Winer J., Jung C.K., Shackel I. And Williams P.M. (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expresion in cardiac myocytes in vitro. Anal. Biochem. 270, 41-49.
39. Wu C.W., Li A.F, Chi C.W., Huang C.L., Shen K.H., Liu W.Y. and Lin W. (2000). Human gastric cancer kinase profile and prognostic significance of MKK4 kinase. Am. J. Pathol. 156, 2007-2015.
40. Xin W., Yuri K.J., Ricci F., Zahurak M., Qiu W., Su G.H., Yeo C.J., Hruban R.H., Kern S.E. and Iacobuzio-Donahue C.A. (2004). MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course. Clin. Cancer Res. 10, 8516-8520.
41. Zhou P., Qian L., Kozopas K.M. and Craig R.W. (1997). Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89, 630-643.